<DOC>
	<DOCNO>NCT00004811</DOCNO>
	<brief_summary>OBJECTIVES : I . Evaluate tolerance patient blastomycosis , histoplasmosis , sporotrichosis different dos itraconazole ( R51,211 ) . II . Determine level itraconazole serum body fluid . III . Assess course illness itraconazole therapy . IV . Determine dosage itraconazole safe well tolerate 80 % -90 % patient estimate potential dosage use future comparative trial .</brief_summary>
	<brief_title>Phase I/II Study Itraconazole Blastomycosis , Histoplasmosis , Sporotrichosis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This study estimate optimal dose oral itraconazole . Patients treat 1 3 dos itraconazole ; start dose patient determine entry . Therapy administer daily 3-6 month . Patients progressive disease may treat next high dose ; may 1 increase . Concurrent systemic topical antifungal prohibit . Patients follow 1 , 3 , 6 , 12 month .</detailed_description>
	<mesh_term>Histoplasmosis</mesh_term>
	<mesh_term>Blastomycosis</mesh_term>
	<mesh_term>Sporotrichosis</mesh_term>
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Cultureproven fungal disease , i.e . : Chronic cavitary histoplasmosis Extrapulmonary histoplasmosis , e.g. , mucosal disease Blastomycosis Sporotrichosis Positive culture last dose prior therapy Requires antifungal therapy amphotericin B ketoconazole No fungal meningitis No central nervous system disease No immediately lifethreatening disease Prior/Concurrent Therapy At least 1 month since therapy disease No 2 mg/kg prior amphotericin B ( total dose ) No 2 mg/kg prior ketoconazole ( total dose ) No concurrent immunosuppressive , include : Corticosteroids Azathioprine Cytotoxic agent Patient Characteristics Hepatic : AST great 3 time normal Alkaline phosphatase great 3 time normal Bilirubin great 3 mg/dL Other : No acquired immunodeficiency syndrome No pregnant nursing woman Effective contraception require fertile woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2001</verification_date>
	<keyword>blastomycosis</keyword>
	<keyword>fungal infection</keyword>
	<keyword>histoplasmosis</keyword>
	<keyword>immunologic disorder infectious disorder</keyword>
	<keyword>rare disease</keyword>
	<keyword>sporotrichosis</keyword>
</DOC>